Transcript from Jury Selection Process for Trial of Martin Shkreli

[Nick H. Supervisor]

Quote

Public Enemy

From the jury selection process that took place over three days in June for the trial of Martin Shkreli, an investor and hedge fund founder who is facing eight counts of securities and wire fraud. In 2015, when Shkreli was CEO of Turing Pharmaceuticals, the company raised the price of its drug Daraprim by 5,000 percent. In 2016, Shkreli was widely criticized for defending the 400 percent increase in the price of EpiPen, an emergency allergy injection sold by Mylan. More than two hundred potential jurors were excused from the trial. Judge Kiyo Matsumoto presided. Benjamin Brafman is a lawyer representing Shkreli.

Read the transcript here

 

Just to give you an idea:

Quote

juror no. 52: When I walked in here today I looked at him, and in my head, that’s a snake — not knowing who he was. I just walked in and looked right at him and that’s a snake.

And juror no. 59's final response is great.